Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Humalog Mix50/50 in Gestational Diabetes
NCT01613807Phase 4Completed
- Sponsor
- Sansum Diabetes Research Institute
- Start
- Oct 2008
- Primary completion
- Jun 2010
- Modality
- Recombinant Proteins and Enzymes
01
Overview
A Phase 4 trial of insulin lispro mix 50/50 in gestational diabetes mellitus (GDM), sponsored by Sansum Diabetes Research Institute. Started Oct 2008; status: completed.
02
Drugs
insulin lispro mix 50/50
03
Conditions
gestational diabetes mellitus (GDM)
Beyond the preview
Go deeper on NCT01613807.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01613807.